References
- Simon, R. (1989). Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials 10(1):1–10. doi:10.1016/0197-2456(89)90015-9.
- Taylor, J. M. G., Braun, T. M., Li, Z. (2006). Comparing an experimental agent to a standard agent: Relative merits of a one-arm or randomized two-arm phase II design. Clinical Trials 3:335–348. doi:10.1177/1740774506070654.
- Tang, H., Foster, N. R., Grothey, A., Ansell, S. M., Goldberg, R. M., Sargent, D. J. (2010). Comparison of error rates in single-arm versus randomized phase II cancer clinical trials. Journal of Clinical Oncology 28(11):1936–1941. doi:10.1200/JCO.2009.25.5489.
- Pond, G. R., Abbasi, S. (2011). Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials. Clinical Trials 8(3):260–269. doi:10.1177/1740774511401764.
- Jung, S.-H. (2008). Randomized phase II trials with a prospective control. Statistics in Medicine 27:568–583. doi:10.1002/(ISSN)1097-0258.
- Shan, G., Ma, C., Hutson, A. D., Wilding, G. E. (2013). Randomized two-stage Phase II clinical trial designs based on Barnard’s exact test. Journal of Biopharmaceutical Statistics 23(5):1081–1090. doi:10.1080/10543406.2013.813525.
- Jung, S.-H., Sargent, D. J. (2014). Randomized Phase II clinical trials. Journal of Biopharmaceutical Statistics 24(4):802–816. doi:10.1080/10543406.2014.901343.
- Cellamare, M., Sambucini, V. (2015). A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach. Statistics in Medicine 34(6):1059–1078. doi:10.1002/sim.v34.6.
- Ayanlowo, A. O., Redden, D. T. (2007). Stochastically curtailed phase II clinical trials. Statistics in Medicine 26:1462–1472. doi:10.1002/(ISSN)1097-0258.
- Chi, Y., Chen, C.-M. (2008). Curtailed two-stage designs in Phase II clinical trials. Statistics in Medicine 27:6175–6189. doi:10.1002/sim.v27:29.
- Phatak, A. G., Bhatt, N. M. (1967). Estimation of the fraction defective in curtailed sampling plans by attributes. Technometrics 9:219–228. doi:10.1080/00401706.1967.10490457.
- Kunz, C. U., Kieser, M. (2012). Curtailment in single-arm two-stage phase II oncology trials. Biometrical Journal 54(4):445–456. doi:10.1002/bimj.v54.4.
- Carsten, C., Chen, P. (2016). Curtailed two-stage matched pairs design in double-arm phase II clinical trials. Journal of Biopharmaceutical Statistics 26(5):816–822. doi:10.1080/10543406.2015.1074921.
- Bersimis, S., Sachlas, A., Papaioannou, T. (2015). Flexible designs for phase II comparative clinical trials involving two response variables. Statistics in Medicine 34:197–214. doi:10.1002/sim.v34.2.
- Lee, J. J., Liu, D. D. (2008). A predictive probability design for phase II cancer clinical trials. Clinical Trials 5(2):93–106. doi:10.1177/1740774508089279.